Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02365467 · ClinicalTrials.gov registry record
Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending TAA and Chronic Dissections
A clinical trial, sponsored by Medtronic Cardiovascular.
- Completed
- Registry status
- 32
- Enrollment target
NCT02365467 is a clinical trial that has completed, run by Medtronic Cardiovascular. The registered enrollment target is 32 participants.
The verdict
NCT02365467 has completed, sponsored by Medtronic Cardiovascular.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The purpose of the Feasibility study is to characterize the safety of the Valiant Mona LSA Thoracic Stent Graft System, including an assessment of the safety and effectiveness of the device acutely and at the 30 day visit in the identified subject population. This study will also evaluate the current instructions for use and may direct changes to the delivery and deployment steps. The purpose of the expansion to the Feasibility Study is to characterize the Valiant Mona LSA Thoracic Stent Graft System, in particular to assess the safety and effectiveness of the device acutely and at the 30 day visit, in subjects enrolled with chronic, Type B dissections.
Interventions
- DEVICE Valiant Mona LSA Thoracic Stent Graft System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-04-16 |
| Est. Completion | 2024-12-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02365467
The ClinicalTrials.gov registry entry for NCT02365467 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Valiant Mona LSA Thoracic Stent Graft System is the first listed.
NCT02365467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02365467 about?
NCT02365467 is a clinical study titled "Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending TAA and Chronic Dissections". The purpose of the Feasibility study is to characterize the safety of the Valiant Mona LSA Thoracic Stent Graft System, including an assessment of the safety and effectiveness of the device acutely and at the 30 day visit in the identified subject population. This study will also evaluate the curren...
What is the current status of trial NCT02365467?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2015-04-16. Estimated completion is 2024-12-05.
What interventions are being tested in trial NCT02365467?
The interventions under investigation include: Valiant Mona LSA Thoracic Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT02365467?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.